Goldman Sachs
HPTX

Goldman Sachs’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Goldman Sachs’s Portfolio HPTX Stock Details HPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-708,867
Closed -$32.5M – 7671
2015
Q1 		$32.5M Buy
+708,867
New +$21.2M 0.01% 1411
2014
Q4 		– Sell
-9,691
Closed -$244K – 7514
2014
Q3 		$244K Buy
+9,691
New +$241K ﹤0.01% 5972

Goldman Sachs's HPTX Position: Q2 2015 in Review

Goldman Sachs sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 708,867 shares — an estimated $32.5M sold.

Goldman Sachs first reported a position in HPTX in Q3 2014 and held it in 2 quarters. The position peaked at $32.5M in Q1 2015. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

  • Goldman Sachs reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Goldman Sachs sold 708,867 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $32.5M.
  • Goldman Sachs first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q3 2014 and held it in 2 quarters.
  • Goldman Sachs's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $32.5M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on Goldman Sachs's 13F filing for Q2 2015, filed 14 Aug 2015.